Marshall University
Do pediatric patients that receive dexmedetomidine as premedication experience less emergence delirium than pediatric patients that receive midazolam as premedication?
Abstract
dc:description.abstractTitle: Do pediatric patients that receive dexmedetomidine as premedication experience less emergence delirium than pediatric patients that receive midazolam as premedication? Problem Statement: Midazolam remains the current choice within the practice for premedication in the prevention of emergence delirium, however as research continues there could possibly be a gap between the research and current practice. Throughout the practice of pediatric anesthesia most providers choose to premedicate with midazolam while there may be a more beneficial option of dexmedetomidine. Results: The study found a significant variance in the incidence of emergence delirium among pediatric patients, ranging from 18.1% to 89%, depending on the scoring system used. The PAED scoring system indicated an 89% incidence with a cutoff of 10 points, while a cutoff of 12 points showed 19.3%. Other scoring systems reported incidences of 18.1% and 18.9%. The findings highlight the variability in diagnosing emergence delirium based on different assessment tools. Overall, the research emphasizes the need for standardized criteria in evaluating the emergence of delirium in pediatric anesthesia.
Degree
thesis:*- Name thesis:degree_name
- Management Practice in Nurse Anesthesia
- Level thesis:degree_level
- Research Paper
- Discipline thesis:degree_discipline
- College of Business
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- McCloud, Shelby
- Contributors dc:contributor
-
- Megan E. Workman, DMP, APRN, CRNA
- Alberto Coustasse, Dr.PH. MD, MBA, MPH
Subjects
dc:subject × 11Identifiers
dc:identifier.*- Repository record dc:identifier
- https://mds.marshall.edu/etd/1873